Manon Marcu

641 total citations
6 papers, 506 citations indexed

About

Manon Marcu is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Manon Marcu has authored 6 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Manon Marcu's work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (2 papers). Manon Marcu is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (2 papers). Manon Marcu collaborates with scholars based in France, Germany and United States. Manon Marcu's co-authors include Chrystelle Brignone, Frédéric Triebel, Caroline Grygar, Bernard Escudier, F. Mefti, Joseph Gligorov, F. Cvitkovic, Jacques Médioni, Maya Gutierrez and Étienne Brain and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Manon Marcu

6 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manon Marcu France	5	442	367	61	39	17	6	506
Giuseppe Cipollone Italy	7	220 0.5×	287 0.8×	68 1.1×	57 1.5×	22 1.3×	15	404
Wolfgang Moersig Germany	7	336 0.8×	251 0.7×	87 1.4×	60 1.5×	17 1.0×	12	432
Davide Bommarito United States	3	248 0.6×	210 0.6×	37 0.6×	45 1.2×	21 1.2×	6	335
Allison Yager United States	3	419 0.9×	285 0.8×	40 0.7×	39 1.0×	37 2.2×	3	459
Xiangyan Qiu China	3	298 0.7×	345 0.9×	41 0.7×	72 1.8×	23 1.4×	6	453
Vernon K. Sondak United States	2	260 0.6×	235 0.6×	42 0.7×	50 1.3×	28 1.6×	3	320
Anita Mohos Hungary	8	445 1.0×	461 1.3×	26 0.4×	89 2.3×	24 1.4×	11	559
Stephanie Mittman United States	6	356 0.8×	377 1.0×	49 0.8×	90 2.3×	22 1.3×	7	516
Annie Tasker Australia	4	286 0.6×	267 0.7×	36 0.6×	50 1.3×	14 0.8×	6	362
Jorge Scutti United States	4	272 0.6×	244 0.7×	21 0.3×	44 1.1×	13 0.8×	4	328

Countries citing papers authored by Manon Marcu

Since Specialization

Citations

This map shows the geographic impact of Manon Marcu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manon Marcu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manon Marcu more than expected).

Fields of papers citing papers by Manon Marcu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manon Marcu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manon Marcu. The network helps show where Manon Marcu may publish in the future.

Co-authorship network of co-authors of Manon Marcu

This figure shows the co-authorship network connecting the top 25 collaborators of Manon Marcu. A scholar is included among the top collaborators of Manon Marcu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manon Marcu. Manon Marcu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Brignone, Chrystelle, Maya Gutierrez, F. Mefti, et al.. (2010). First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity. Journal of Translational Medicine. 8(1). 71–71. 202 indexed citations

2.

Brignone, Chrystelle, Bernard Escudier, Caroline Grygar, Manon Marcu, & Frédéric Triebel. (2009). A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma. Clinical Cancer Research. 15(19). 6225–6231. 178 indexed citations

3.

Triebel, Frédéric, et al.. (2008). IMP321 and weekly paclitaxel as first-line chemoimmunotherapy for metastatic breast cancer (MBC). Journal of Clinical Oncology. 26(15_suppl). 1045–1045. 4 indexed citations

4.

Brignone, Chrystelle, Caroline Grygar, Manon Marcu, Knut Schäkel, & Frédéric Triebel. (2007). A Soluble Form of Lymphocyte Activation Gene-3 (IMP321) Induces Activation of a Large Range of Human Effector Cytotoxic Cells. The Journal of Immunology. 179(6). 4202–4211. 60 indexed citations

5.

Brignone, Chrystelle, Caroline Grygar, Manon Marcu, Gaëlle Perrin, & Frédéric Triebel. (2007). IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study. Vaccine. 25(24). 4641–4650. 32 indexed citations

6.

Brignone, Chrystelle, Caroline Grygar, Manon Marcu, Gaëlle Perrin, & Frédéric Triebel. (2007). IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study. PubMed. 5(1). 5–5. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact